What is Supriya Lifescience Ltd. Quarterly Revenue?

Supriya Lifescience Ltd. Quarterly Revenue Supriya Lifescience Jun-2026 Quarterly Revenue is Rs 192 Cr which is growth of 30.2% YoY.

What is Supriya Lifescience Ltd. Quarterly Net Profit?

Supriya Lifescience Ltd. Quarterly Net Profit Supriya Lifescience Jun-2026 Quarterly Net Profit is Rs 24 Cr which is growth of -30.9% YoY.

What is Supriya Lifescience Ltd. Annual Revenue?

Supriya Lifescience Ltd. Annual Revenue Supriya Lifescience Mar-2026 Annual Revenue is Rs 839 Cr which is growth of 18.8% YoY.

What is Supriya Lifescience Ltd. Annual Net Profit?

Supriya Lifescience Ltd. Annual Net Profit Supriya Lifescience Mar-2026 Annual Net Profit is Rs 209 Cr which is growth of 11.3% YoY.

What is Supriya Lifescience Ltd. Total Shareholders Fund?

Supriya Lifescience Ltd. Total Shareholders Fund Supriya Lifescience Mar-2026 Total Shareholders Fund is Rs 1,198 Cr which is growth of 20.2% YoY.

What is Supriya Lifescience Ltd. Total Assets?

Supriya Lifescience Ltd. Total Assets Supriya Lifescience Mar-2026 Total Assets is Rs 1,357 Cr which is growth of 22.0% YoY.

What is Supriya Lifescience Ltd. Book Value Per Share?

Supriya Lifescience Ltd. Book Value Per Share Supriya Lifescience Mar-2026 Book Value Per Share is 149 Rs which is growth of 20.2% YoY.

What is Supriya Lifescience Ltd. ROE?

Supriya Lifescience Ltd. ROE Supriya Lifescience Mar-2026 ROE is 17% which is growth of 1.4% YoY.

What is Supriya Lifescience Ltd. Cash From Operating Activity?

Supriya Lifescience Ltd. Cash From Operating Activity Supriya Lifescience Mar-2026 Cash From Operating Activity is Rs 186 Cr which is growth of 12.8% YoY.

What is Supriya Lifescience Ltd. Net Cash Flow?

Supriya Lifescience Ltd. Net Cash Flow Supriya Lifescience Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -106.8% YoY.

Supriya Lifescience Ltd.

NSE: SUPRIYA | BSE: 543434

Mid-range Performer

Download real time

-12.75(-1.44%)

60.08% Gain from 52W Low

210.9K

NSE+BSE Volume

NSE 19 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Supriya Lifescience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Supriya Lifescience share price target, revenues, EPS, net income and more

Supriya Lifescience quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Supriya Lifescience Jun-2026 Quarterly Revenue is Rs 192 Cr which is growth of 30.2% YoY.
NEGATIVE
Quarterly Net Profit Supriya Lifescience Jun-2026 Quarterly Net Profit is Rs 24 Cr which is growth of -30.9% YoY.

Supriya Lifescience Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	192.4	280	209.1	202.6	147.8	187.1	187.8	168.6	162.9	160.4	143.1	142.6	134.9
SR_Q Operating Rev.	189.8	276.5	206.4	199.8	145.1	184.1	185.7	166.1	160.6	158.2	140.1	140.1	132
OI_Q Other Income	2.7	3.5	2.6	2.7	2.7	3	2.1	2.5	2.2	2.2	3.1	2.5	2.9
OEXPNS_Q Operating Exp.	142.3	178.9	134.4	127.2	93.4	116.5	119.7	101.4	98.1	102.7	98.6	108.3	87.5
OEXPNS_Q Operating Exp.	142.3	178.9	134.4	127.2	93.4	116.5	119.7	101.4	98.1	102.7	98.6	108.3	87.5
OP_Q Operating Profit	47.5	97.6	72.1	72.7	51.7	67.6	66	64.7	62.5	55.5	41.5	31.8	44.5
OPMPCT_Q Operating Profit Margin %	25.01%	35.30%	34.92%	36.35%	35.64%	36.71%	35.53%	38.96%	38.94%	35.09%	29.62%	22.66%	33.70%
DEP_Q Depr.	8.9	8.5	6.8	6.6	6.5	6.1	5	4.7	4.7	3.9	4	4	4
INT_Q Interest	0.4	0.5	0.5	0.4	0.5	0.4	0.5	0.4	0.3	0.6	0.5	0.5	0.8
PBT_Q Profit Before Tax	40.8	92.1	66.9	68.3	47.4	64.1	62.6	62.1	59.8	53.2	40.1	29.8	42.6
TAX_Q Tax	16.8	17.9	17.2	17.9	12.6	13.7	15.8	15.9	15.1	16.2	10.3	5.9	14.1
NP_Q Net Profit	24	74.2	49.7	50.4	34.8	50.4	46.8	46.2	44.6	36.9	29.8	23.9	28.5
EPS_adj_Q EPS Adj. latest	3	9.2	6.2	6.3	4.3	6.3	5.8	5.7	5.6	4.6	3.7	3	3.5
NP_TTM Net profit TTM	198.4	209.1	185.3	182.4	178.1	188	174.5	157.5	135.3	119.1	120.4	100.1	93.1
EPS_TTM Basic EPS TTM	24.7	26	23	22.7	22.1	23.4	21.7	19.6	16.8	14.8	15	12.4	11.6
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Supriya Lifescience competitor comparison and performance snapshot within industry

Supriya Lifescience annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Supriya Lifescience Mar-2026 Annual Revenue is Rs 839 Cr which is growth of 18.8% YoY.
POSITIVE
Annual Net Profit Supriya Lifescience Mar-2026 Annual Net Profit is Rs 209 Cr which is growth of 11.3% YoY.

Supriya Lifescience Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
SR_A Total Rev. Ann. ⌄	21.3%	16.2%	884	839.4	706.3	581	470.4	537.6	396.2	321.9	284.3	222.9
TotalOperatingRevenues_A Operating Rev. Ann.	21.6%	16.5%	872.5	827.9	696.5	570.4	460.9	530.1	385.4	311.6	277.8	212.9
OI_A Other Income Ann.	6.6%	1.1%	11.5	11.5	9.8	10.6	9.5	7.6	10.9	10.3	6.5	10
OEXPNS_A Operating Exp. Ann.	17.2%	19.6%	582.7	533.8	435.7	397.4	332	316.1	218.1	213	211.9	191.7
OEXPNS_A Operating Exp. Ann.	17.2%	19.6%	582.7	533.8	435.7	397.4	332	316.1	218.1	213	211.9	191.7
OP_A Operating Profit Ann.	31.6%	11.9%	289.8	294.1	260.8	173	128.9	214	167.3	98.6	65.9	21.2
OPMPCT_A OPM Ann. %	8.5%	-3.7%		35.03%	36.92%	29.77%	27.40%	39.80%	42.22%	30.64%	23.19%	9.52%
TotalExpenses_A Total Exp. Ann. ⌄	17.6%	19.8%		564.1	457.8	415.3	346.9	330.4	228.9	225.2	227	207.2
OtherExpenses_A Other Exp. Ann.	24.1%	26.2%	201.6	183.1	144	108	95.7	71.2	57.2	46.5	39.2	32.1
EmployeeBenefitExpenses_A Employee Exp. Ann.	20.3%	24.1%	102.5	96.7	80.5	67.6	55.6	49.1	32.8	25.7	19.1	17.6
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	30.2%	11.4%		305.5	270.6	183.6	138.4	221.6	178.2	108.9	72.4	31.2
EBIDTPCT_A EBITDA Ann. margin %	7.4%	-4.1%		36.40%	38.31%	31.60%	29.42%	41.21%	44.96%	33.83%	25.46%	14.00%
INT_A Interest Ann.	-15.1%	-14.3%	1.8	1.9	1.7	2.1	3.1	4.2	4.1	6.1	9.8	10.7
DEP_A Depr.	34%	33.1%	30.9	28.4	20.4	15.8	11.8	10.1	6.8	6.1	5.2	4.8
PBT_A PBT Ann.	30.6%	10.4%	268.2	274.8	248.5	165.7	123.5	207.2	167.3	96.8	57.3	15.7
TAX_A Tax Ann.	25%	8.5%	69.8	65.7	60.5	46.6	33.6	55.4	43.7	24.6	16	4.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	32.5%	11.1%		209.1	188	119.1	89.9	151.8	123.6	72.2	41.3	11.5
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	32.5%	11.1%	198.4	209.1	188	119.1	89.9	151.8	123.6	72.2	41.3	11.5
NETPCT_A NPM Ann. %	9%	-4.7%		25.25%	26.98%	20.88%	19.49%	28.64%	32.07%	23.15%	14.86%	5.41%
EPS_adj_A EPS Adj. latest Ann.	32.4%	11%		26	23.4	14.8	11.2	18.9	15.4	9	5.1	1.4
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

18.8%

2Y CAGR

20.2%

3Y CAGR

21.3%

5Y CAGR

16.2%

7Y CAGR

16.7%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

11.2%

2Y CAGR

32.5%

3Y CAGR

32.5%

5Y CAGR

11.1%

7Y CAGR

26.1%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

22.5%

2Y CAGR

15.9%

3Y CAGR

17.2%

5Y CAGR

19.6%

7Y CAGR

14.1%

Operating Expenses Annual Cr growth is higher than historical averages.

Supriya Lifescience balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Supriya Lifescience Mar-2026 Total Shareholders Fund is Rs 1,198 Cr which is growth of 20.2% YoY.
POSITIVE
Total Assets Supriya Lifescience Mar-2026 Total Assets is Rs 1,357 Cr which is growth of 22.0% YoY.

Supriya Lifescience Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	19.6%	34.8%	1,197.7	996.8	815.4	699.5	615.7	268.6	149.9	96.6	56.9
EQCAP_A Equity Share Capital Ann.	0%	2%	16.1	16.1	16.1	16.1	16.1	14.6	14.6	14.6	14.6
TotalShareCapital_A Total Share Capital Ann.	0%	2%	16.1	16.1	16.1	16.1	16.1	14.6	14.6	14.6	14.6
ReservesAndSurplus_A Reserves Plus Surplus Ann.	20%	36%	1,181.6	980.7	799.3	683.4	599.6	254	133.1	79.7	37
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	20%	36%	1,181.6	980.7	799.3	683.4	599.6	254	135.3	82	42.3
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	15.3%	4.4%	38.3	33.4	29	25	19.4	30.9	31.7	21.9	44.8
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	31.6%	31.3%	31.2	27	23.2	13.7	11.2	8	7.8	7.3	6.8
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-1.9%	-24.8%	5.2	5.1	5	5.5	5.3	21.6
CL_A Total Current Liabilities Ann. ⌄	8.1%	-3.7%	121	82.2	76.9	95.8	99.7	146	153.6	132.7	144.2
TradePayables_A Trade Payables Ann.	20%	16.8%	110.9	74.6	59.6	64.2	49	51	49.4	44.2	41.9
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-15.5%	-20.1%	8.5	6.4	17	14.1	29	26.1	22.5	3.7	5.5
ShortTermProvisions_A ST Provisions Ann.	28.6%	2.5%	1.7	1.2	0.4	0.8	0.4	1.5	2.8	4.6	3.1
TL_A Total Capital Plus Liabilities Ann.	18.3%	25%	1,357.1	1,112.3	921.2	820.3	734.8	445.5	335.2	251.2	245.9
FixedAssets_A Fixed Assets Ann. ⌄	30.1%	32.3%	724.7	600.9	459	329.2	233.2	178.8	137	117.9	125.4
TangibleAssets_A Tangible Assets Ann.	38.2%	47.5%	687.8	451.5	308.5	260.4	188.3	98.4	95.3	82.5	91
IntangibleAssets_A Intangible Assets Ann.	5.7%	-4.1%	1.3	1.4	1.7	1.1	1.5	1.6	1.4		1.2
CapitalWorkInProgress_A Capital Work In Progress Ann.	-19.2%	-14.7%	35.6	148	148.8	67.6	43.4	78.8	40.2	35.4	33.2
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	32.4%	35.7%	824.8	675.3	523.4	355.4	237.2	179.3	138.7	118.2	127.3
NonCurrentInvestments_A Non Current Investments Ann.	57.3%	296.9%	98.5	63.2	63.8	25.3	0.1	0.1	0.1	0.1	0.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-						0.4	1.7	0.3	1.8
OtherNonCurrentAssets_A Other Non Current Assets Ann.	21.1%	-	1.6	11.2	0.7	0.9	4
CA_A Total Current Assets Ann. ⌄	4.6%	14.9%	532.3	437	397.8	464.9	497.5	266.2	196.5	133	118.6
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	37.4%	24.5%	219.5	134.4	111.7	84.7	115.2	73.5	52.5	60.2	53.9
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-20.6%	-3.1%	78.9	79.2	75	157.6	227.9	92.3	74.7	12.4	8.6
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	0%	-12.9%	0.6	0.9	0.7	0.6	0.6	1.2	19.9	29.6	24.4
OtherCurrentAssets_A Other Current Assets Ann.	-11.5%	22.5%	73.8	104.3	125.2	106.3	61.6	26.7
TA_A Total Assets Ann.	18.3%	25%	1,357.1	1,112.3	921.2	820.3	734.8	445.5	335.2	251.2	245.9
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	16.3%	40.6%	8.8	4.2	3.5	5.6	5.6	1.6
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	57.3%	296.9%	98.5	63.2	63.8	25.3	0.1	0.1	0.1	0.1	0.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

22%

2Y CAGR

21.4%

3Y CAGR

18.3%

5Y CAGR

25%

7Y CAGR

27.2%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

47.2%

2Y CAGR

25.4%

3Y CAGR

8.1%

5Y CAGR

-3.7%

7Y CAGR

-1.3%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

20.2%

2Y CAGR

21.2%

3Y CAGR

19.6%

5Y CAGR

34.8%

7Y CAGR

43.3%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Supriya Lifescience ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Supriya Lifescience Mar-2026 Book Value Per Share is 149 Rs which is growth of 20.2% YoY.
POSITIVE
ROE Supriya Lifescience Mar-2026 ROE is 17% which is growth of 1.4% YoY.

Supriya Lifescience Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
BVSH_A BVSH Ann.	19.6%	32.3%	148.8	123.8	101.3	86.9	76.5	36.7	101	64.4	35.3
ROA_A RoA Ann. %	12%	-11.1%	15.40%	16.89%	12.92%	10.95%	20.66%	27.74%	21.52%	16.44%	4.69%
ROE_A ROE Ann. %	10.8%	-17.6%	17.45%	18.85%	14.60%	12.84%	24.65%	46.01%	48.83%	43.81%	22.33%
ROCE_A ROCE Ann. %	8.7%	-17.1%	22.42%	24.28%	19.87%	17.47%	33.29%	57.23%	56.65%	56.66%	25.90%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	7.1%	-4.4%	36.90%	38.85%	32.19%	30.02%	41.80%	46.22%	34.95%	26.05%	14.65%
PBITMargin_A EBIT Ann. Margin %	6.8%	-5.5%	33.47%	35.91%	29.41%	27.45%	39.89%	44.47%	33.01%	24.16%	12.38%
PBTMargin_A PBT Ann. Margin %	7.4%	-5.2%	33.19%	35.67%	29.04%	26.79%	39.09%	43.41%	31.04%	20.63%	7.37%
NETPCT_A NPM Ann. %	9%	-4.7%	25.25%	26.98%	20.88%	19.49%	28.64%	32.07%	23.15%	14.86%	5.41%
ASETTO_A Asset Turnover Ann. %	5.3%	-6.9%	0.7	0.7	0.7	0.6	0.9	1	1.1	1.1	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-3.5%	19.6%	4.4	5.3	5.2	4.9	5	1.8	1.3	1	0.8
QuickRatio_A Quick Ratio Ann.	-4.9%	19%	3.1	3.9	4.1	3.6	4.1	1.3	1	0.8	0.6
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0	0	0	0.1		-	-	-	-
EarningRetention_A Earning Retention Ann. %	0.5%	-0.1%	96.16%	96.58%	95.95%	94.63%	97.11%	96.70%	79.72%
CashEarningRetention_A Cash Earning Retention Ann. %	0.5%	-0.1%	96.62%	96.92%	96.43%	95.26%	97.29%	96.88%	81.29%
CashEarningRetention_A Cash Earning Retention Ann. %	0.5%	-0.1%	96.62%	96.92%	96.43%	95.26%	97.29%	96.88%	81.29%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	47.5%	-	4,469.3	5,824.8	2,595.1	1,393.9	3,760.5
EVPerNetSales_A EV Per Net Sales Ann.	21.6%	-	5.4	8.4	4.6	3	7.1	-	-	-	-
PBV_A Price To Book Value Adjusted	-16.4%	-24.4%	5.87	7.76	8.62	10.05	11.42	23.8	8.65	13.56	24.75
EVPerEBITDA_A EV Per EBITDA Ann.	13.1%	-	14.6	21.5	14.1	10.1	17	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	18.6%	-	5.5	8.5	4.7	3.3	7.5	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	0.5%	-0.1%	96.15%	96.57%	95.94%	94.62%	97.10%	96.69%	79.71%
EYield_A Earnings Yield Ann.	0%	-	0.1	0	0	0.1	0
DEBT_CE_A Total Debt to Total Equity Ann.						0	0	0.3	0.6	1	2.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-7.4%

2Y CAGR

9.3%

3Y CAGR

10.8%

5Y CAGR

-17.6%

7Y CAGR

-12.3%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-8.8%

2Y CAGR

9.2%

3Y CAGR

12%

5Y CAGR

-11.1%

7Y CAGR

-0.9%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-17%

2Y CAGR

-8%

3Y CAGR

-3.5%

5Y CAGR

19.6%

7Y CAGR

23.6%

Current Ratio Annual is falling faster than historical averages.

Supriya Lifescience cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Supriya Lifescience Mar-2026 Cash From Operating Activity is Rs 186 Cr which is growth of 12.8% YoY.
NEGATIVE
Net Cash Flow Supriya Lifescience Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -106.8% YoY.

Supriya Lifescience Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18
CFO_A Cash from Operating Act. Ann. ⌄	41.1%	18.7%	185.8	164.7	113.3	66.2	48.8	78.9	116.7	49	27
PBT_A PBT Ann.	30.6%	10.4%	274.8	248.5	165.7	123.5	207.2	167.3	96.8	57.3	15.7
INT_A Interest Ann.	-15.1%	-14.3%	1.9	1.7	2.1	3.1	4.2	4.1	6.1	9.8	10.7
TAX_A Tax Ann.	25%	8.5%	65.7	60.5	46.6	33.6	55.4	43.7	24.6	16	4.2
CFI_A Cash from Investing Act. Ann.	-	-	-176.2	-152.2	-173.6	-133.1	-59.8	-46.8	-40.6	5.1	-3.6
CFA_A Cash from Financing Act. Ann.	-	-	-9.9	-8.2	-22.4	-3.4	149.7	-14.5	-13.8	-50.3	-20.4
NCF_A Net Cash Flow Ann. ⌄	-	-	-0.3	4.2	-82.6	-70.3	138.6	17.6	62.3	3.8	3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-29.7%	1.2%	79.2	75	157.6	227.9	89.3	74.7	12.4	8.6	5.6
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-20.6%	-3.1%	78.9	79.2	75	157.6	227.9	92.3	74.7	12.4	8.6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

12.8%

2Y CAGR

28.1%

3Y CAGR

41.1%

5Y CAGR

18.7%

7Y CAGR

21%

Cash from Operating Activity Annual growth is lower than historical averages.

Supriya Lifescience investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

60.08% Gain from 52W Low

Supriya Lifescience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Supriya Lifescience - Forecaster

Forecaster Analyst Estimates for Supriya Lifescience share price target, revenues, EPS, net income and more